Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: A role in endothelial cell activation

Transplantation

Volumn 80, Issue 2, 2005, Pages 264-271

  Lawson, Charlotte ^a,b   Holder, Angela L ^a   Stanford, Rachel E ^a   Smith, John ^a   Rose, Marlene L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Adhesion molecules; Antibodies; Cardiac transplantation

Indexed keywords

AZATHIOPRINE; COMPLEMENTARY DNA; CYCLOSPORIN A; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CARDIAC GRAFT REJECTION; CHO CELL; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIBODY FORMATION; AZATHIOPRINE; BASE SEQUENCE; CHO CELLS; CRICETINAE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MUTATION, MISSENSE; MYCOPHENOLIC ACID;

EID: 23044485917     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000165433.88295.4C     Document Type: Article

References (48)

1. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74(1): 13.
2. Printseva O, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1: Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992; 140(4): 889.
3. Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85(2): 199.
4. Nakashima Y, Raines EW, Plump AS, et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998; 18(5): 842.
5. Dietrich H, Hu Y, Zou Y, et al. Mouse model of transplant arteriosclerosis: Role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 2000; 20(2): 343.
6. Poston RS, Mann MJ, Hoyt EG, et al. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. Transplantation 1999; 68(6): 825.
7. Ferry BL, Welsh KI, Dunn MJ, et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection. Transpl Immunol 1997; 5(1): 17.
8. Crisp SJ, Dunn MJ, Rose ML, et al. Antiendothelial antibodies after heart transplantation: The accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant 1994; 13(1 pt 1): 81.
9. Wheeler CH, Collins A, Dunn MJ, et al. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant 1995; 14(6 pt 2): S188.
10. Fredrich R, Toyoda M, Czer LS, et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 1999; 67(3): 385.
11. Dunn MJ, Crisp SJ, Rose ML, et al. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339(8809): 1566.
12. Jurcevic S, Dunn MJ, Crisp S, et al. A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. Transplantation 1998; 65(9): 1197.
13. Faulk WP, Rose M, Meroni PL, et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 1999; 60(9): 826.
14. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137(1): 245.
15. Vora DK, Rosenbloom CL, Beaudet AL, et al. Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994; 21(3): 473.
16. McLaren AJ, Marshall SE, Haldar NA, et al. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999; 55(5): 1977.
17. Wellicome SM, Thornhill MH, Pitzalis C, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990; 144(7): 2558.
18. Lidington EA, Rao RM, Marelli-Berg FM, et al. Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol 2002; 282(1): C67.
19. Lawson C, Ainsworth M, Yacoub M, et al. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J Immunol 1999; 162(5): 2990.
20. Smith KG, Isbel NM, Catton MG, et al. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13(1): 160.
21. Rose ML, Smith J, Dureau G, et al. Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant 2002; 21(2): 282.
22. Borozdenkova S, Smith J, Marshall S, et al. Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation. Hum Immunol 2001; 62(3): 247.
23. Pober JS, Lapierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: Comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987; 138(10): 3319.
24. Clayton A, Evans RA, Pettit E, et al. Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 1998; 111(pt4): 443.
25. Lawson C, Ainsworth ME, McCormack AM, et al. Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: Induction of VCAM-1 but no proliferation. Cardiovasc Res 2001; 50(3): 547.
26. Koyama Y, Tanaka Y, Saito K, et al. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription. J Immunol 1996; 157(11): 5097.
27. Sano H, Nakagawa N, Chiba R, et al. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem Biophys Res Commun 1998; 250(3): 694.
28. Schmid E, Muller TH, Budzinski RM, et al. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J Interferon Cytokine Res 1995; 15(9): 819.
29. Perrey C, Brenchley PE, Johnson RW, et al. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 1998; 6(2): 101.
30. Sumitran-Karuppan S, Tyden G, Reinholt F, et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5(4): 321.
31. Sumitran-Holgersson S, Wilczek HE, Holgersson J, et al. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002; 74(2): 268.
32. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352(6): 558.
33. Le Bas-Bernardet S, Hourmant M, Coupel S, et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3(2): 167.
34. Fedoseyeva EV, Tam RC, Popov IA, et al. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996; 61(5): 679.
35. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71(7): 886.
36. Barber LD, Whitelegg A, Madrigal JA, et al. Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation 2004; 77(10): 1604.
37. Labarrere CA, Nelson DR, Miller SJ, et al. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure. Circulation 2000; 102(13): 1549.
38. Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: Pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 1999; 259(2): 255.
39. Warraich RS, Pomerance A, Stanley A, et al. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 2000; 69(8): 1609.
40. Triolo G, Accardo-Palumbo A, Carbone MC, et al. IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus: Induction of adhesion molecule expression in cultured endothelial cells. Clin Exp Immunol 1998; 111(3): 491.
41. Carvalho D, Savage CO, Isenberg D, et al. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999; 42(4): 631.
42. Lee KH, Cho HJ, Kim HS, et al. Activation of extracellular signal regulated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behcet's disease. J Dermatol Sci 2002; 30(1): 63.
43. Yamamoto T, Takahashi Y, Kuno S, et al. Effects of anti-endothelial cell antibody in pre-eclampsia on endothelin-1 release from cultured endothelial cells. Immunol Cell Biol 1997; 75(4): 340.
44. Smith JD, Lawson C, Yacoub MH, et al. Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies. Int Immunol 2000; 12(4): 563.
45. Harris PE, Bian H, Reed EF. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: A possible mechanism for transplant atherosclerosis. J Immunol 1997; 159(11): 5697.
46. Bian H, Harris PE, Reed EF. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol 1998; 10(9): 1315.
47. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 2000; 28(9): 1379.
48. Taylor PM, Rose ML, Yacoub MH, et al. Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation 1992; 54(3): 451.